Read + Share
Awadie H, Waterman M. Intermittent Appearance of Antibodies to Infliximab Is Not Associated With
Reduced Efficacy in Patients With Inflammatory Bowel Diseases. J Clin Gastroenterol 2022;56:e47-e51.
PMID: 33252556
|
 |
|
Awadie H, Waterman M. Intermittent Appearance of Antibodies to Infliximab Is Not Associated With
Reduced Efficacy in Patients With Inflammatory Bowel Diseases. J Clin Gastroenterol 2022;56:e47-e51.
PMID: 33252556
|
|
|
|